UK – Synthon B.V. v Teva Pharmaceutical Industries Limited

Posted: May 8th, 2017

The Court of Appeal recently handed down its decision in Synthon BV v Teva Pharmaceutical Industries Limited, upholding Birss J’s decision at first instance that Teva’s patent relating to glatiramer acetate (“GA”) (EP (UK) 2 361 924) was valid but that claim 20 and dependent claims were invalid for added matter. GA is a mixture […]


UK – Fujifilm Kyowa Kirin Biologics v. AbbVie

Posted: April 3rd, 2017

Fujifilm Kyowa Kirin Biologics Co., Ltd (1) Samsung Bioepis UK Limited, (2) Biogen Idec Limited v AbbVie Biotechnology Limited, High Court of England and Wales, (Henry Carr J), London, UK, 3 March 2017, Neutral Citation Number: [2017] EWHC 395 (Pat) In this judgment, Henry Carr J granted Fujifilm Kyowa Biologics (FKB) and Samsung Bioepis/Biogen Idec […]


UK – Epoch Company Limited v. Character Options Limited

Posted: March 27th, 2017

Epoch Company Limited v Character Options Limited, UK, Intellectual Property Enterprise Court, Hacon HHJ, 22 March 2017 This case concerned a UK patent directed to a toy comprising transparent decorative beads made of water soluble resin. In use such beads are arranged on a tray in a desired pattern. Water is then sprayed on the […]


UK – Edwards Lifesciences LLC v Boston Scientific

Posted: March 7th, 2017

Edwards Lifesciences LLC v Boston Scientific Scimed Inc, UK, High Court, Hacon HHJ sitting as a Deputy High Court Judge, 3 March 2017 These proceedings concerned an application brought by Edwards Lifesciences LLC (“Edwards”) seeking revocation of two European Patents (UK) – EP (UK) 2 749 254 and EP (UK) 2 926 766 – owned […]


GR – Novartis & Novartis Hellas v. GPH

Posted: February 16th, 2017

Novartis AG & Novartis Hellas SA v. GPH Ltd, Greece , First Instance Court of Athens (temporary relief proceedings), 21 December 2016, Judgment No. 8512/2016 Novartis AG and its Greek subsidiary, Novartis Hellas,  initiated successful temporary relief proceedings against GPH Ltd in defense of their rights to EP No. 2292219 (EP 219), which covers a […]


UK – Jushi Group v. OCV Intellectual Capital

Posted: February 16th, 2017

Jushi Group Co., Ltd v OCV Intellectual Capital, LLC, Intellectual Property Enterprise Court (HHJ Hacon), 6 February 2017, Neutral Citation Number [2017] EWHC 171 (IPEC) This case is interesting for the approach taken by the UK court in a situation where the patent in suit claims ranges that overlap with ranges disclosed in the prior […]


UK – Wobben v Siemens / Appeal

Posted: February 10th, 2017

Wobben Properties GmbH v. Siemens plc & Ors, UK, Court of Appeal (Civil Division), Kitchin LJ, Longmore LJ, Floyd LJ, 19 January 2017, Neutral Citation Number: [2017] EWCA Civ 5 This is an appeal against the judgment of Birss J of 20 July 2015, in which he held that Wobben’s patent was invalid for lack […]


NO – EcoLice AS/Sea Lice Research Norway AS v. Sinkaberg-Hansen AS, Bindalslaks AS

Posted: January 16th, 2017

The proceedings concerned the validity of the Norwegian patent 330244, owned by Sea Lice Research Norway AS, and to which Ecolice had been granted a license. The patent was directed to a treatment against sea lice which is a major problem in Norwegian aquaculture. More precisely, claim 1 of the patent related to use of […]


UK – Hospira v. Genentech

Posted: January 10th, 2017

Hospira UK Limited v Genentech Inc., Court of Appeal, Lord Justice Longmore, Lord Justice Kitchin and Lord Justice Floyd, 30 November 2016 The Court of Appeal has upheld that the Swiss-form claim of Genentech’s patent relating to the use of the monoclonal antibody trastuzumab in combination with a taxane (paclitaxel) for the treatment of HER2-positive […]